GAM
BIIB icon

Generali Asset Management’s Biogen BIIB Stock Holding History

Generali Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.64M Buy
35,374
+1,180
+3% +$226K 0.14% 143
2026
Q1 		$6.27M Buy
34,194
+7,013
+26% +$1.29M 0.13% 153
2025
Q4 		$4.78M Sell
27,181
-13,744
-34% -$2.25M 0.1% 193
2025
Q3 		$5.73M Sell
40,925
-757
-2% -$102K 0.12% 160
2025
Q2 		$5.23M Buy
41,682
+2,518
+6% +$314K 0.12% 171
2025
Q1 		$5.36M Buy
39,164
+22,969
+142% +$3.28M 0.13% 168
2024
Q4 		$2.48M Buy
+16,195
New +$2.73M 0.06% 288

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Generali Asset Management's BIIB Position: Q2 2026 in Review

Generali Asset Management increased its Biogen (BIIB) stake by 3.5% in Q2 2026, buying an estimated $226K and bringing the position to 35,374 shares worth $7.64M. The position accounts for 0.14% of the portfolio, ranked #143.

Generali Asset Management first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Generali Asset Management held 35,374 shares of Biogen worth $7.64M as of Q2 2026.
  • Generali Asset Management bought 1,180 Biogen shares in Q2 2026, an estimated $226K.
  • Biogen made up 0.14% of Generali Asset Management's portfolio in Q2 2026, its #143 holding.
  • Generali Asset Management first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.